Eam Global Investors LLC Bellus Health Inc. Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$8.22 - $10.76 $4.03 Million - $5.28 Million
-490,709 Reduced 84.08%
92,884 $763,000
Q3 2022

Nov 14, 2022
BUY
$8.95 - $12.0 $5.22 Million - $7 Million
583,593 New
583,593 $6.19 Million
Q2 2020

Aug 13, 2020
SELL
$8.88 - $11.15 $4.84 Million - $6.07 Million
-544,795 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$5.77 - $10.85 $3.14 Million - $5.91 Million
544,795 New
544,795 $5.44 Million

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0
View Full List

About BELLUS Health Inc.

BLU Quotes by TradingView
  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email